BioHealth News Archive

Why you need to know NEA’s Scott Frederick – Washington Business Journal

Why you need to know NEA’s Scott Frederick – Washington Business Journal

He is a walking Rolodex of some of the nation’s most high-powered business leaders. And he’s the reason many startups feel they’ve gotten a…

Read More
Chinese money floods US biotech as Beijing chases new cures | afr.com

Chinese money floods US biotech as Beijing chases new cures | afr.com

Chinese investors are pumping money into US drug startups as Beijing seeks to become a global leader in new medicines, adding to a flood of…

Read More
Maryland Biotechs Dominate 2018 Vaccine Industry Excellence Awards – BioBuzz

Maryland Biotechs Dominate 2018 Vaccine Industry Excellence Awards – BioBuzz

More than a dozen biotech companies or researchers from the Maryland biotech cluster, which some have also dubbed ‘Vaccine Alley’, were among the most…

Read More
Global Cities Challenge America’s High-Tech Dominance – CityLab

Global Cities Challenge America’s High-Tech Dominance – CityLab

We hear a lot these days about the so-called “rise of the rest”—the ascent of second-tier American cities such as Pittsburgh, St. Louis, Detroit,…

Read More
FounderTrac’s First of Two Cohorts in 2018 Was a Standing Room Only Event with Aimee Martin of MileMarker Winning a $25k Investment from MCVC Partners! | Business Wire

FounderTrac’s First of Two Cohorts in 2018 Was a Standing Room Only Event with Aimee Martin of MileMarker Winning a $25k Investment from MCVC Partners! | Business Wire

On Tuesday, April 3, 2018 TEDCO Incubation Challenge finalist FounderTrac had their first Demo Day at Host Sponsor Loews Annapolis Hotel. After a 12…

Read More
Chinese funds pour US$1.4b into US biotechnology firms in the first three months of the year – South China Morning Post

Chinese funds pour US$1.4b into US biotechnology firms in the first three months of the year – South China Morning Post

Venture capital funds based in China poured US$1.4 billion into private US biotechnology firms in the three months ending March 31, accounting for about…

Read More
New Members Join NIIMBL to Advance Biomanufacturing

New Members Join NIIMBL to Advance Biomanufacturing

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a proud member of Manufacturing USA® is pleased to welcome Genentech, Celgene, Merck, MilliporeSigma and…

Read More

New Enterprise Associates the most active venture firm in Q1 2018

The first quarter of 2018 saw a decline in investments, given that global deal activity decreased by 4 percent. Despite the fewer deals, global…

Read More
Last Week to Register: BHCR Forum 2018 – HHS Secretary Alex M. Azar II Confirmed

Last Week to Register: BHCR Forum 2018 – HHS Secretary Alex M. Azar II Confirmed

Don't let your colleagues miss out -- Forward this message to other senior leadership in the Region to invite them to attend the 2018…

Read More
THOUSANDS of vaccines to be made available due to growing terror – Daily Star

THOUSANDS of vaccines to be made available due to growing terror – Daily Star

The disease, caused by a bacteria producing toxic substances which lead to internal bleeding, swelling and tissue death, is listed as the main biological…

Read More
New Enterprise Associates, Y Combinator, Khosla Ventures, Andreessen Horowitz, GV and Greycroft top ranking of most active Q1 venture investors – Silicon Valley Business Journal

New Enterprise Associates, Y Combinator, Khosla Ventures, Andreessen Horowitz, GV and Greycroft top ranking of most active Q1 venture investors – Silicon Valley Business Journal

Y Combinator has broadened its investment focus beyond the seed funding it gives to startups in its accelerator batches, and has become one of…

Read More
GSK divests line of rare disease drugs

GSK divests line of rare disease drugs

GlaxoSmithKline divested its portfolio of rare disease gene therapies to Orchard Therapeutics through a strategic agreement, the company announced April 12. {iframe}https://www.beckershospitalreview.com/supply-chain/gsk-divests-line-of-rare-disease-drugs.html{/iframe}

Read More
Hopkins teams with Lockheed Martin to enhance STEM programming for Baltimore students | Hub

Hopkins teams with Lockheed Martin to enhance STEM programming for Baltimore students | Hub

The Johns Hopkins University and Lockheed Martin today announced a partnership aimed at enhancing opportunities for Baltimore City public school students pursuing academic and…

Read More
Emergent BioSolutions Announces Successful Completion of Mutual Recognition Procedure for Market Authorization of BioThrax in European Countries

Emergent BioSolutions Announces Successful Completion of Mutual Recognition Procedure for Market Authorization of BioThrax in European Countries

Emergent BioSolutions Inc. (NYSE:EBS) today announced the successful completion of the Mutual Recognition Procedure (MRP) for market authorization of BioThrax® (Anthrax Vaccine Adsorbed) in…

Read More
NHLBI 70th Anniversary Lecture Series

NHLBI 70th Anniversary Lecture Series

This year marks the 70th Anniversary of the National Heart, Lung, and Blood Institute (NHLBI). NHLBI began as the National Heart Institute on June…

Read More